TH89976B - Iwabradine delta crystal form. Hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing it - Google Patents

Iwabradine delta crystal form. Hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing it

Info

Publication number
TH89976B
TH89976B TH601004998A TH0601004998A TH89976B TH 89976 B TH89976 B TH 89976B TH 601004998 A TH601004998 A TH 601004998A TH 0601004998 A TH0601004998 A TH 0601004998A TH 89976 B TH89976 B TH 89976B
Authority
TH
Thailand
Prior art keywords
iwabradine
hydrochloride
crystal form
substance
preparation
Prior art date
Application number
TH601004998A
Other languages
Thai (th)
Other versions
TH89976A (en
Inventor
นางสาวมารี-โนแอล โอกุส นายเจราร์ด ดาเมียง นายสตีเฟน ฮอร์วาธ
Original Assignee
เลส์ ลาบอราตัวเรส์ แซร์วีแยร์
Filing date
Publication date
Application filed by เลส์ ลาบอราตัวเรส์ แซร์วีแยร์ filed Critical เลส์ ลาบอราตัวเรส์ แซร์วีแยร์
Publication of TH89976A publication Critical patent/TH89976A/th
Publication of TH89976B publication Critical patent/TH89976B/en

Links

Abstract

รูปฟอร์มผลึก S ของไอวาบราดีน ไฮโดรคลอไรด์ของสูตร (I) (สูตรเคมี) แสดงลักษณะเฉพาะจากไดอะแกรมการเลี้ยวเบนรังสี X แบบผงของมัน: Iwabradine S crystal form The hydrochloride of the formula (I) (chemical formula) characterizes from its powder X-ray diffraction diagram:

Claims (1)

1. รูปฟอร์มผลึก S ของไอวาบราดีน ไฮโดรคลอไรด์ของสูตร (I) (สูตรเคมี) (I), แสดงลักษณะเฉพาะจากไดอะแกรมการเลี้ยวเบนรังสี X แบบผงดังต่อไปนี้, วัดโดยใช้เครื่องวัดการ เลี้ยวเบน PANalytical X'Pert Pro ควบคู่กับ เครื่องตรวจหา X'Celertor และ แสดงค่าในเทอมของ ตำแหน่งไลน์ (มุม2ธีต้า Bragg's, แสดงค่าในหน่วยองศา), ความสูงไลน์ (แสดงค่าในหน่วยนับ), พื้นที่บริเวณไลน์ (แสดงค่าในหน่วยนับX องศ:1.Iwabradine S-crystal form The hydrochloride of formula (I) (chemical formula) (I), characterizes from the following powder X-ray diffraction diagram, was measured using the PANalytical X'Pert Pro diffraction meter together with the instrument. Detects X'Celertor and displays the value in the term of the line position (2 Bragg's theta angle, display in degrees), line height (display in counts), line area area. (Show the value in units X degrees:
TH601004998A 2006-10-10 Iwabradine delta crystal form. Hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing it TH89976B (en)

Publications (2)

Publication Number Publication Date
TH89976A TH89976A (en) 2008-06-10
TH89976B true TH89976B (en) 2008-06-10

Family

ID=

Similar Documents

Publication Publication Date Title
HRP20080406T3 (en) Crystalline form gamma of the chlorhydrate of ivabradine, process for its preparation and pharmaceutical composition containing it
HRP20080418T3 (en) Crystalline form beta-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
HRP20080520T3 (en) Crystalline form beta of the chlorhydrate of ivabradine, process for its preparation and pharmaceutical composition containing it
JP2015531653A5 (en)
TW200833326A (en) Chemical compounds 572
ATE517099T1 (en) GLUCOPYRANOSYL-SUBSTITUTED BENZONITRILE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS, THEIR USE AND PRODUCTION PROCESS THEREOF
AR056931A1 (en) GAMMA D CRYSTALLINE FORM OF IVABRADINE CHLORHYDRATE, A PROCEDURE FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, AND USES IN CARDIOVASCULAR DISORDERS
EA201071409A1 (en) NEW SALTS (4 - {[(5 - {[(3-CHLOROPHENIL) METHYL] OXY} -2-METHYLPHENYL) CARBONYL] AMINO} -3-METHYLPHENYL) ACETIC ACID
EP2272837A4 (en) LIQUID CRYSTAL COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE
MX2009006010A (en) Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases.
Chen et al. Discovery of 2-chloro-N-((4, 4-difluoro-1-hydroxycyclohexyl) methyl)-5-(5-fluoropyrimidin-2-yl) benzamide as a potent and CNS penetrable P2X7 receptor antagonist
ES2314593T3 (en) ALFA CRYSTAL FORM OF STRONTIUM RANELATE, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
EP2535329A3 (en) Spiro-piperidine derivatives
TH89976B (en) Iwabradine delta crystal form. Hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing it
IL190636A0 (en) Quinazoline derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments useful for treating or preventing flaviviridae infection
TH89977B (en) Iwabradine delta d form Hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing it
TH89977A (en) Iwabradine delta d form Hydrochloride, the process for the preparation of the substance and the pharmaceutical composition containing it
WO2007099323A3 (en) Quinoline derivatives
TH89976A (en)
FR2926992B1 (en) FORMULATION OF AN INJECTABLE PARACETAMOL SOLUTION, PROCESS FOR PREPARING AND PACKAGING SUCH A SOLUTION AND DEVICE FOR CONDITIONING SUCH A SOLUTION
TH81393A (en) Yd crystal form of Iwabradine hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing the substance
WO2008064829A3 (en) Novel aminothienopyridinone derivatives processes for preparing them and pharmaceutical compositions thereof
TH81390A (en) Crystal-Beta form Of ivabradine hydrochloride, the process for the preparation of this substance And pharmaceutical components in which this substance is
TH81391B (en) Iwabradine hydrochloride Bd crystal form, the process for the preparation of the substance and the pharmaceutical mixtures containing the substance
TH81393B (en) Yd crystal form of Iwabradine hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing the substance